Departments of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Ophthalmic Plast Reconstr Surg. 2020 Jan/Feb;36(1):45-48. doi: 10.1097/IOP.0000000000001456.
To evaluate the effectiveness and safety of aponeurotic blepharoptosis surgery and the morphology of filtering bleb in patients with filtrating bleb.
This retrospective case series included 7 consecutive patients (9 eyes) with filtering bleb after trabeculectomy. They underwent transcutaneous levator aponeurotic advancement from May 2018 to April 2019. The authors evaluated margin reflex distance-1 and intraocular pressure and analyzed filtering bleb morphology, such as filtering bleb volume, filtering bleb height, and filtering bleb wall thickness, using anterior segment optical coherence tomography before and after aponeurotic advancement. The authors also evaluated intra and postoperative complications.
The mean age was 75.6 ± 7.8 years; the mean duration from glaucoma surgery to blepharoptosis surgery was 36.9 ± 26.8 months; the mean follow-up after blepharoptosis surgery was 6.1 ± 2.9 months. The mean margin reflex distance-1 value changed significantly from 0.7 ± 0.8 mm before surgery to 3.3 ± 0.4 mm after surgery (p < 0.0001). The mean intraocular pressure showed no significant change from 12.9 ± 2.6 mm Hg before surgery to 12.7 ± 3.3 after surgery. In the filtering bleb analysis using anterior segment optical coherence tomography no significant differences were found, such as in bleb volume, height and wall thickness, before and after blepharoptosis surgery. There were no intraoperative complications in any of the cases. A postoperative corneal disorder was seen in 1 eye, but there was no infection of or damage to filtering bleb in any of the cases during the postoperative follow-up period.
In patients with glaucoma filtering bleb, transcutaneous levator aponeurotic ptosis surgery is considered to be safe and unlikely to affect the morphology of the filtering bleb or intraocular pressure in the short term.In patients with glaucoma filtering bleb, transcutaneous levator aponeurotic ptosis surgery is considered to be highly safe and unlikely to affect the morphology of the filtering bleb or intraocular pressure in the short term.
评估经皮提上睑肌腱膜切开术治疗滤过泡相关上睑下垂的疗效和安全性,并分析滤过泡形态。
本回顾性病例系列研究纳入了 2018 年 5 月至 2019 年 4 月间因滤过泡相关上睑下垂而行经皮提上睑肌腱膜切开术的 7 例(9 只眼)患者。采用眼前节光学相干断层扫描(AS-OCT)分别于术前和术后评估患者的最大上睑缘移动度(MRD1)和眼压,并分析滤过泡形态,包括滤过泡容积、滤过泡高度和滤过泡壁厚度。同时评估了患者的术中及术后并发症。
患者的平均年龄为 75.6±7.8 岁;从青光眼手术到上睑下垂手术的平均时间为 36.9±26.8 个月;上睑下垂手术后的平均随访时间为 6.1±2.9 个月。与术前相比,术后患者的 MRD1 值从 0.7±0.8mm 显著增加至 3.3±0.4mm(p<0.0001),而眼压则从术前的 12.9±2.6mmHg 降至术后的 12.7±3.3mmHg,差异无统计学意义。AS-OCT 分析显示,术前和术后滤过泡的容积、高度和壁厚度差异均无统计学意义。所有患者术中均无并发症发生。术后 1 只眼出现角膜混浊,但在术后随访期间,所有患者的滤过泡均未发生感染或损伤。
经皮提上睑肌腱膜切开术治疗青光眼滤过泡相关上睑下垂安全有效,短期内不会影响滤过泡形态和眼压。